BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mollnes TE, Storm BS, Brekke OL, Nilsson PH, Lambris JD. Application of the C3 inhibitor compstatin in a human whole blood model designed for complement research – 20 years of experience and future perspectives. Seminars in Immunology 2022. [DOI: 10.1016/j.smim.2022.101604] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lo MW, Amarilla AA, Lee JD, Albornoz EA, Modhiran N, Clark RJ, Ferro V, Chhabra M, Khromykh AA, Watterson D, Woodruff TM. SARS-CoV-2 triggers complement activation through interactions with heparan sulfate. Clin Transl Immunology 2022;11:e1413. [PMID: 35999893 DOI: 10.1002/cti2.1413] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Mastellos DC, Lambris JD. Recent developments in C3-targeted complement therapeutics. Semin Immunol 2022;:101645. [PMID: 35915008 DOI: 10.1016/j.smim.2022.101645] [Reference Citation Analysis]